• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医源性喉气管狭窄患者免疫微环境的定量评估。

Quantitative Assessment of the Immune Microenvironment in Patients With Iatrogenic Laryngotracheal Stenosis.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA.

出版信息

Otolaryngol Head Neck Surg. 2021 Jun;164(6):1257-1264. doi: 10.1177/0194599820978271. Epub 2020 Dec 8.

DOI:10.1177/0194599820978271
PMID:33290179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8169517/
Abstract

OBJECTIVE

Iatrogenic laryngotracheal stenosis (iLTS) is characterized by fibroinflammatory narrowing of the upper airway and is most commonly caused by intubation injury. Evidence suggests a key role for CD4 T cells in its pathogenesis. The objective of this study is to validate emerging multiplex immunofluorescence (mIF) technology for use in the larynx and trachea while quantitatively characterizing the immune cell infiltrate in iLTS. In addition to analyzing previously unstudied immune cell subsets, this study aims to validate previously observed elevations in the immune checkpoint PD-1 and its ligand PD-L1 while exploring their spatial and cellular distributions in the iLTS microenvironment.

STUDY DESIGN

Controlled ex vivo cohort study.

SETTING

Tertiary care center.

METHODS

mIF staining was performed with formalin-fixed, paraffin-embedded slides from 10 patients with iLTS who underwent cricotracheal resection and 10 control specimens derived from rapid autopsy for CD4, CD8, CD20, FoxP3, PD-1, PD-L1, and cytokeratin.

RESULTS

There was greater infiltration of CD4 T cells, CD8 T cells, CD20 B cells, FoxP3CD4 Tregs, and FoxP3CD8 early effector T cells in the submucosa of iLTS specimens as compared with controls ( < .05 for all). PD-1 was primarily expressed on T cells and PD-L1 predominantly on CD4 cells and "other" cells.

CONCLUSION

This study leverages the power of mIF to quantify the iLTS immune infiltrate in greater detail. It confirms the highly inflammatory nature of iLTS, with CD4 cells dominating the immune cell infiltrate; it further characterizes the cellular and spatial distribution of PD-1 and PD-L1; and it identifies novel immunologic targets in iLTS.

摘要

目的

医源性喉气管狭窄(iLTS)的特征是上呼吸道纤维炎性狭窄,最常见的原因是插管损伤。有证据表明 CD4 T 细胞在其发病机制中起关键作用。本研究的目的是验证新兴的多重免疫荧光(mIF)技术在喉和气管中的应用,同时定量描述 iLTS 中的免疫细胞浸润。除了分析以前未研究过的免疫细胞亚群外,本研究旨在验证以前观察到的免疫检查点 PD-1 及其配体 PD-L1 的升高,同时探索它们在 iLTS 微环境中的空间和细胞分布。

研究设计

对照性离体队列研究。

设置

三级保健中心。

方法

用 10 例接受环气管切开术的 iLTS 患者的福尔马林固定、石蜡包埋切片和 10 例快速尸检对照标本进行 mIF 染色,检测 CD4、CD8、CD20、FoxP3、PD-1、PD-L1 和细胞角蛋白。

结果

与对照组相比,iLTS 标本的黏膜下有更多的 CD4 T 细胞、CD8 T 细胞、CD20 B 细胞、FoxP3CD4 Treg 和 FoxP3CD8 早期效应 T 细胞浸润(所有 P 值均 <.05)。PD-1 主要在 T 细胞上表达,PD-L1 主要在 CD4 细胞和“其他”细胞上表达。

结论

本研究利用 mIF 的力量更详细地量化 iLTS 的免疫浸润。它证实了 iLTS 的高度炎症性质,CD4 细胞主导免疫细胞浸润;它进一步描述了 PD-1 和 PD-L1 的细胞和空间分布;并确定了 iLTS 中的新免疫靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/c48a8cc32dc4/nihms-1659353-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/316a64e298ce/nihms-1659353-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/8ecc91c5cf01/nihms-1659353-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/419da26c9402/nihms-1659353-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/7fe648977d2a/nihms-1659353-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/c48a8cc32dc4/nihms-1659353-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/316a64e298ce/nihms-1659353-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/8ecc91c5cf01/nihms-1659353-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/419da26c9402/nihms-1659353-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/7fe648977d2a/nihms-1659353-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d514/8169517/c48a8cc32dc4/nihms-1659353-f0005.jpg

相似文献

1
Quantitative Assessment of the Immune Microenvironment in Patients With Iatrogenic Laryngotracheal Stenosis.医源性喉气管狭窄患者免疫微环境的定量评估。
Otolaryngol Head Neck Surg. 2021 Jun;164(6):1257-1264. doi: 10.1177/0194599820978271. Epub 2020 Dec 8.
2
Increased Expression of PD-1 and PD-L1 in Patients With Laryngotracheal Stenosis.PD-1 和 PD-L1 在喉气管狭窄患者中的表达增加。
Laryngoscope. 2021 May;131(5):967-974. doi: 10.1002/lary.28790. Epub 2020 Jun 17.
3
T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.辅助性T细胞2淋巴细胞免疫表型与医源性喉气管狭窄相关。
Laryngoscope. 2019 Jan;129(1):177-186. doi: 10.1002/lary.27321. Epub 2018 Nov 13.
4
M2 Macrophages Promote Collagen Expression and Synthesis in Laryngotracheal Stenosis Fibroblasts.M2 巨噬细胞促进喉气管狭窄成纤维细胞中胶原的表达和合成。
Laryngoscope. 2021 Feb;131(2):E346-E353. doi: 10.1002/lary.28980. Epub 2020 Aug 17.
5
Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.医源性喉气管狭窄与II型糖尿病中成纤维细胞的特征分析
Laryngoscope. 2021 Jul;131(7):1570-1577. doi: 10.1002/lary.29026. Epub 2020 Aug 28.
6
Identifying Phenotypically Distinct Fibroblast Subsets in Type 2 Diabetes-Associated Iatrogenic Laryngotracheal Stenosis.鉴定 2 型糖尿病相关医源性喉气管狭窄中表型不同的成纤维细胞亚群。
Otolaryngol Head Neck Surg. 2022 Apr;166(4):712-719. doi: 10.1177/01945998211014790. Epub 2021 Jun 15.
7
Phenotypic Epithelial Changes in Laryngotracheal Stenosis.喉气管狭窄的表型上皮改变。
Laryngoscope. 2022 Nov;132(11):2194-2201. doi: 10.1002/lary.30040. Epub 2022 Feb 10.
8
Fibroblasts in Hypoxic Conditions Mimic Laryngotracheal Stenosis.低氧条件下的成纤维细胞模拟喉气管狭窄。
Otolaryngol Head Neck Surg. 2017 May;156(5):886-892. doi: 10.1177/0194599817697049. Epub 2017 Mar 28.
9
Quantification of Inflammatory Markers in Laryngotracheal Stenosis.喉气管狭窄中炎症标志物的定量分析
Otolaryngol Head Neck Surg. 2017 Sep;157(3):466-472. doi: 10.1177/0194599817706930. Epub 2017 May 9.
10
Inhibition of glutaminase to reverse fibrosis in iatrogenic laryngotracheal stenosis.抑制谷氨酰胺酶逆转医源性喉气管狭窄的纤维化。
Laryngoscope. 2020 Dec;130(12):E773-E781. doi: 10.1002/lary.28493. Epub 2020 Jan 6.

引用本文的文献

1
Airway stenosis: classification, pathogenesis, and clinical management.气道狭窄:分类、发病机制及临床管理
MedComm (2020). 2025 Jan 26;6(2):e70076. doi: 10.1002/mco2.70076. eCollection 2025 Feb.
2
PD-L1 Acts Independently of PD-1 as a Marker of Pathologic Fibroblasts in Laryngotracheal Stenosis.在喉气管狭窄中,程序性死亡配体1(PD-L1)作为病理性成纤维细胞的标志物,其作用独立于程序性死亡受体1(PD-1)。
Otolaryngol Head Neck Surg. 2025 Feb;172(2):563-570. doi: 10.1002/ohn.1034. Epub 2024 Oct 23.
3
Amelioration of Subglottic Stenosis by Antimicrobial Peptide Eluting Endotracheal Tubes.

本文引用的文献

1
Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know?医源性喉气管狭窄发病机制中的炎症通路:我们了解多少?
Transl Cancer Res. 2020 Mar;9(3):2108-2116. doi: 10.21037/tcr.2020.01.21.
2
Increased Expression of PD-1 and PD-L1 in Patients With Laryngotracheal Stenosis.PD-1 和 PD-L1 在喉气管狭窄患者中的表达增加。
Laryngoscope. 2021 May;131(5):967-974. doi: 10.1002/lary.28790. Epub 2020 Jun 17.
3
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.
抗菌肽洗脱气管内导管改善声门下狭窄
Cell Mol Bioeng. 2023 Jun 29;16(4):369-381. doi: 10.1007/s12195-023-00769-9. eCollection 2023 Aug.
4
Tracheal microbiome and metabolome profiling in iatrogenic subglottic tracheal stenosis.医源性声门下气管狭窄的气管微生物组和代谢组特征分析。
BMC Pulm Med. 2023 Sep 26;23(1):361. doi: 10.1186/s12890-023-02654-7.
5
Sirolimus-eluting airway stent reduces profibrotic Th17 cells and inhibits laryngotracheal stenosis.西罗莫司洗脱气道支架减少致纤维化的 Th17 细胞并抑制喉气管狭窄。
JCI Insight. 2023 Jun 8;8(11):e158456. doi: 10.1172/jci.insight.158456.
6
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults.成人良性气管和会厌下狭窄的分子机制和生理变化。
Int J Mol Sci. 2022 Feb 22;23(5):2421. doi: 10.3390/ijms23052421.
7
Persistent Inflammation and Nitric Oxide Dysregulation Are Transcriptomic Blueprints of Subglottic Stenosis.持续性炎症和一氧化氮失调是声门下狭窄的转录组蓝图。
Front Immunol. 2021 Dec 20;12:748533. doi: 10.3389/fimmu.2021.748533. eCollection 2021.
8
Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade.错配修复缺陷型前列腺癌伴实质脑转移,采用免疫检查点阻断治疗。
Cold Spring Harb Mol Case Stud. 2021 Aug 2;7(4). doi: 10.1101/mcs.a006094. Print 2021 Aug.
PD-L1 与 T 细胞的结合促进了自身耐受性,并抑制了癌症中相邻的巨噬细胞和效应 T 细胞。
Nat Immunol. 2020 Apr;21(4):442-454. doi: 10.1038/s41590-020-0620-x. Epub 2020 Mar 9.
4
Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles.转化生长因子-β诱导成纤维细胞表达并将免疫调节蛋白 PD-L1 释放到细胞外囊泡中。
FASEB J. 2020 Feb;34(2):2213-2226. doi: 10.1096/fj.201902354R. Epub 2019 Dec 12.
5
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis.预测PD-1/PD-L1检查点阻断反应的生物标志物模式比较:一项系统评价和荟萃分析。
JAMA Oncol. 2019 Aug 1;5(8):1195-1204. doi: 10.1001/jamaoncol.2019.1549.
6
Laryngotracheal Microbiota in Adult Laryngotracheal Stenosis.成人喉气管狭窄中的喉气管微生物组。
mSphere. 2019 May 1;4(3):e00211-19. doi: 10.1128/mSphereDirect.00211-19.
7
PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.PD-L1 在浸润性成纤维细胞中驱动特发性肺纤维化的纤维化。
JCI Insight. 2019 Mar 21;4(6). doi: 10.1172/jci.insight.125326.
8
Efficacy of PD-1 blockade in cervical cancer is related to a CD8FoxP3CD25 T-cell subset with operational effector functions despite high immune checkpoint levels.尽管免疫检查点水平较高,但 PD-1 阻断在宫颈癌中的疗效与具有操作效应功能的 CD8FoxP3CD25T 细胞亚群有关。
J Immunother Cancer. 2019 Feb 12;7(1):43. doi: 10.1186/s40425-019-0526-z.
9
Health Care Costs and Cost-effectiveness in Laryngotracheal Stenosis.喉气管狭窄的医疗费用及成本效益
Otolaryngol Head Neck Surg. 2019 Apr;160(4):679-686. doi: 10.1177/0194599818815068. Epub 2018 Nov 27.
10
T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.辅助性T细胞2淋巴细胞免疫表型与医源性喉气管狭窄相关。
Laryngoscope. 2019 Jan;129(1):177-186. doi: 10.1002/lary.27321. Epub 2018 Nov 13.